iBET works in a broad range of fields that encompass multidisciplinary approaches ranging from basic, technological to clinical and translational research, from the development of complex biopharmaceuticals and novel therapies to areas in food and health, including nutraceuticals development and agro-forestry.
Thursday
On November 13th, iBETXplore Open Day showcased the main outputs and achievements of the 13 funded projects
Tuesday
iBET participates in a project that aims to develop an advanced biological and personalised ventricular assist device (BioVAD)
Thursday
Naiara Fernández presented a communication on extraction of biopolysaccharides using alternative solvents
Thursday
The inauguration ceremony was presided by the CEO of the Healthcare Business of Merck KGaA, Belén Garijo, and the CEO of iBET, Paula Alves
